News Conference News ESC 2023 NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm Todd Neale August 25, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions Todd Neale June 20, 2023
News Daily News Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation Todd Neale June 14, 2023
News Conference News ESOC 2023 ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy Todd Neale May 25, 2023
News Conference News ESOC 2023 ELAN: Early DOACs Safe, May Help After Ischemic Stroke in AF Patients Todd Neale May 24, 2023
News Daily News A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4 Shelley Wood April 14, 2023
News Daily News SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO Todd Neale March 28, 2023
News Daily News Acute AF Can Recur: Manage and Monitor Long-term, Says AHA Michael O'Riordan March 16, 2023
News Daily News LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis Todd Neale February 24, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
News Conference News ISC 2023 Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke Todd Neale February 08, 2023
News Daily News Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke Todd Neale December 21, 2022
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE Todd Neale October 19, 2022